SBI Contra Fund
The scheme seeks to provide the investor with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities following a contrarian investment strategy.
Growthvine rating: 4/5 — ranked #2 of 5 in category.
Fund basics
| Category | Equity: Contra |
|---|
| NAV | ₹380.60 (as of 2026-11-09) |
|---|
| AUM | ₹45,068 Cr |
|---|
| Expense ratio | 1.27% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Dinesh Balachandran |
|---|
| Exit load | 0.25% for redemption within 30 days. 0.1% for redemption after 30 days and within 90 days |
|---|
Performance & risk
| 5-year annualised return | 12.49% |
|---|
| Sharpe ratio | 0.27 |
|---|
| Standard deviation | 14.40% |
|---|
| Max drawdown | −60.19% |
|---|
| Alpha | -0.06 |
|---|
| Beta | 0.9 |
|---|
Over 5 years, captured 95.2% of Nifty 500's upside and 74.3% of its downside.
Market cap allocation
| Large cap | 56.7% |
|---|
| Mid cap | 27.7% |
|---|
| Small cap | 15.6% |
|---|
Concentration
| Top 5 holdings | 20.3% |
|---|
| Top 10 holdings | 32.8% |
|---|
| Total holdings | 90 |
|---|
| Index overlap | 37.0% |
|---|
| Active share | 63.0% |
|---|
Top holdings
- TREPS — 6.4%
- HDFC Bank Ltd. — 4.8%
- Reliance Industries Ltd — 4.7%
- ICICI Bank Ltd. — 4.4%
- Biocon Ltd. — 3.3%
- Kotak Mahindra Bank Ltd. — 3.2%
- Punjab National Bank — 2.9%
- INDUS TOWERS LIMITED — 2.7%
- TORRENT POWER LIMITED — 2.5%
- Gail (India) Ltd. — 2.3%
Top sectors
- Banking & Financial — 20.8%
- Pharma & Biotech — 6.7%
- Cash — 5.9%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −4.6% | — | — |
| 2025 | 6.1% | — | — |
| 2024 | 18.8% | — | — |
| 2023 | 38.2% | — | — |
| 2022 | 12.8% | — | — |